Cargando…
CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy
BACKGROUND: The clinical value of left ventricular (LV) global longitudinal strain (GLS) in the differential diagnosis of light-chain cardiac amyloidosis (AL-CA) and hypertrophic cardiomyopathy (HCM) has been previously reported. In this study, we analyzed the potential clinical value of the LV long...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188937/ https://www.ncbi.nlm.nih.gov/pubmed/37206101 http://dx.doi.org/10.3389/fcvm.2023.1108408 |
_version_ | 1785042972327280640 |
---|---|
author | Wang, Fangqing Deng, Yan Li, Shunjia Cheng, Qichao Wang, Qing Yu, Dexin Wang, Qian |
author_facet | Wang, Fangqing Deng, Yan Li, Shunjia Cheng, Qichao Wang, Qing Yu, Dexin Wang, Qian |
author_sort | Wang, Fangqing |
collection | PubMed |
description | BACKGROUND: The clinical value of left ventricular (LV) global longitudinal strain (GLS) in the differential diagnosis of light-chain cardiac amyloidosis (AL-CA) and hypertrophic cardiomyopathy (HCM) has been previously reported. In this study, we analyzed the potential clinical value of the LV long-axis strain (LAS) to discriminate AL-CA from HCM. Furthermore, we analyzed the association between all the LV global strain parameters derived from cardiac magnetic resonance (CMR) feature tracking and LAS in both the AL-CA and HCM patients to assess the differential diagnostic efficacies of these global peak systolic strains. MATERIALS AND METHODS: Thus, this study enrolled 89 participants who underwent cardiac MRI (CMRI), consisting of 30 AL-CA patients, 30 HCM patients, and 29 healthy controls. The intra- and inter-observer reproducibility of the LV strain parameters including GLS, global circumferential strain (GCS), global radial strain (GRS), and LAS were assessed in all the groups and compared. Receiver operating characteristic (ROC) curve analysis was performed to determine the diagnostic performances of the CMR strain parameters in discriminating AL-CA from HCM. RESULTS: The intra- and inter-observer reproducibility of the LV global strains and LAS were excellent (range of interclass correlation coefficients: 0.907–0.965). ROC curve analyses showed that the differential diagnostic performances of the global strains in discriminating AL-CA from HCM were good to excellent (GRS, AUC = 0.921; GCS, AUC = 0.914; GLS, AUC = 0.832). Furthermore, among all the strain parameters analyzed, LAS showed the highest diagnostic efficacy in differentiating between AL-CA and HCM (AUC = 0.962). CONCLUSION: CMRI-derived strain parameters such as GLS, LAS, GRS, and GCS are promising diagnostic indicators that distinguish AL-CA from HCM with high accuracy. LAS showed the highest diagnostic accuracy among all the strain parameters. |
format | Online Article Text |
id | pubmed-10188937 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101889372023-05-18 CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy Wang, Fangqing Deng, Yan Li, Shunjia Cheng, Qichao Wang, Qing Yu, Dexin Wang, Qian Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: The clinical value of left ventricular (LV) global longitudinal strain (GLS) in the differential diagnosis of light-chain cardiac amyloidosis (AL-CA) and hypertrophic cardiomyopathy (HCM) has been previously reported. In this study, we analyzed the potential clinical value of the LV long-axis strain (LAS) to discriminate AL-CA from HCM. Furthermore, we analyzed the association between all the LV global strain parameters derived from cardiac magnetic resonance (CMR) feature tracking and LAS in both the AL-CA and HCM patients to assess the differential diagnostic efficacies of these global peak systolic strains. MATERIALS AND METHODS: Thus, this study enrolled 89 participants who underwent cardiac MRI (CMRI), consisting of 30 AL-CA patients, 30 HCM patients, and 29 healthy controls. The intra- and inter-observer reproducibility of the LV strain parameters including GLS, global circumferential strain (GCS), global radial strain (GRS), and LAS were assessed in all the groups and compared. Receiver operating characteristic (ROC) curve analysis was performed to determine the diagnostic performances of the CMR strain parameters in discriminating AL-CA from HCM. RESULTS: The intra- and inter-observer reproducibility of the LV global strains and LAS were excellent (range of interclass correlation coefficients: 0.907–0.965). ROC curve analyses showed that the differential diagnostic performances of the global strains in discriminating AL-CA from HCM were good to excellent (GRS, AUC = 0.921; GCS, AUC = 0.914; GLS, AUC = 0.832). Furthermore, among all the strain parameters analyzed, LAS showed the highest diagnostic efficacy in differentiating between AL-CA and HCM (AUC = 0.962). CONCLUSION: CMRI-derived strain parameters such as GLS, LAS, GRS, and GCS are promising diagnostic indicators that distinguish AL-CA from HCM with high accuracy. LAS showed the highest diagnostic accuracy among all the strain parameters. Frontiers Media S.A. 2023-05-03 /pmc/articles/PMC10188937/ /pubmed/37206101 http://dx.doi.org/10.3389/fcvm.2023.1108408 Text en © 2023 Wang, Deng, Li, Cheng, Wang, Yu and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Wang, Fangqing Deng, Yan Li, Shunjia Cheng, Qichao Wang, Qing Yu, Dexin Wang, Qian CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy |
title | CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy |
title_full | CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy |
title_fullStr | CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy |
title_full_unstemmed | CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy |
title_short | CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy |
title_sort | cmr left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188937/ https://www.ncbi.nlm.nih.gov/pubmed/37206101 http://dx.doi.org/10.3389/fcvm.2023.1108408 |
work_keys_str_mv | AT wangfangqing cmrleftventricularstrainsbeyondgloballongitudinalstrainindifferentiatinglightchaincardiacamyloidosisfromhypertrophiccardiomyopathy AT dengyan cmrleftventricularstrainsbeyondgloballongitudinalstrainindifferentiatinglightchaincardiacamyloidosisfromhypertrophiccardiomyopathy AT lishunjia cmrleftventricularstrainsbeyondgloballongitudinalstrainindifferentiatinglightchaincardiacamyloidosisfromhypertrophiccardiomyopathy AT chengqichao cmrleftventricularstrainsbeyondgloballongitudinalstrainindifferentiatinglightchaincardiacamyloidosisfromhypertrophiccardiomyopathy AT wangqing cmrleftventricularstrainsbeyondgloballongitudinalstrainindifferentiatinglightchaincardiacamyloidosisfromhypertrophiccardiomyopathy AT yudexin cmrleftventricularstrainsbeyondgloballongitudinalstrainindifferentiatinglightchaincardiacamyloidosisfromhypertrophiccardiomyopathy AT wangqian cmrleftventricularstrainsbeyondgloballongitudinalstrainindifferentiatinglightchaincardiacamyloidosisfromhypertrophiccardiomyopathy |